We are interested in products or technologies at different stages of development to complement our strong portfolio across our core therapeutic areas and that offer a unique benefit to patients. Specifically, we are looking for assets with proof-of-concept clinical data, including new indications, new format or device-medicine combination, or modified drug release technology to improve symptom relief or increase patients’ compliance to treatment.  

Our Core Therapeutic Areas 

• Gastroenterology:

  covers the gastrointestinal tract from the stomach to intestines and their associated organs
  

  Gastroenterology

  In gastroenterology, Abbott has developed a wide range of treatments, covering the gastrointestinal tract from the stomach to intestines and their associated organs. Our gastroenterology solutions are available in over 100 emerging countries across the world. Our main medicines in this therapeutic area are indicated for pancreatic exocrine insufficiency, liver disease, dyspepsia and gastroparesis, IBS, constipation, and gut health.

  We are striving to deliver differentiated solutions across all major gastroenterological disorders to meet the needs of patients. We are looking for partners who share the same ambition, the same dedication and with whom we can make a difference.

  Submit Innovation
  Submit Innovation

• Women's Health:

  supporting different stages of her life.
   
   
  

  Women's Health

  Abbott is committed to supporting women during every stage of their lives. From menstruation as a teenager, to pregnancy support, to changes following menopause during middle age, our Women’s Health portfolio support women to be their best all along their lives. With our market-leading position in progesterone hormone therapy and a focus on menstruation health, Assisted Reproduction Technology (ART) and menopause care, we look forward to partnering with external parties on the development and commercialization of differentiated medicines for our patients.

  Submit Innovation
  Submit Innovation

• Cardiometabolic:

  focus on dyslipidemia, hypertension, and co-morbidities of diabetes
   
  

  Cardiometabolic

  In the Cardiometabolic therapeutic area, our main current medicines target dyslipidemia, hypertension, and co-morbidities of diabetes, often as second-line treatment.

  We are interested to hear from innovative external parties who are looking to explore partnering with us on the development and commercialization of differentiated medicines to address cardiovascular and metabolic diseases.

  
  Submit Innovation
  
  Submit Innovation

• CNS/Pain:

  focus on vertigo, epilepsy and psychiatric disorders and pain management
  

  Pain/Central Nervous System

  Diseases of the central nervous system and pain can have a huge impact on peoples’ lives. Our main medicines in this therapeutic area are indicated for vertigo, epilepsy, bipolar disorder, depression and obsessive-compulsive disorder, as well as acute and chronic pain.

  If you have a differentiated medicine or innovative solution for CNS diseases/pain and seek for a strong partner to conduct the development and commercialization of your products in emerging countries, we are interested to explore opportunities with you.

  Submit Innovation
  Submit Innovation

• Respiratory Disease:

  prevent and treat both acute and chronical respiratory tract diseases
  

  Respiratory Disease

  Our respiratory franchise spans from flu vaccines, to anti-infectives, to cough and cold medicines. With our focus on preventing and treating both acute and chronical respiratory tract diseases, we are looking to partner with external parties on the development and commercialization of differentiated medicines, vaccines, or drug delivery mechanisms for the people we serve in emerging markets.

  
  Submit Innovation
  Submit Innovation

• Digital Health:

  improve patient care and medicine through innovative digital technology
  

  Digital Health

  Digital technologies can support innovative ways to improve patient care through efficient personalized approaches. We are looking to enrich our portfolio with medically proven digital solutions that fit with our strategic therapeutic areas (Cardiometabolic, Women’s Health, Gastroenterology, CNS/Pain).

  Considering the specificities of our markets, your digital product should be easy to prescribe to patients, and easy to use, aiming at improving their symptoms or curing their disease without taking additional time from healthcare professionals. Ideally, such solution should have already obtained a reimbursement in one or several countries. If you have relevant digital assets, we can discuss ways to collaborate and leverage our robust footprint in emerging countries to help expand access to unique digital tools.

  Submit Innovation
  Submit Innovation

• Gastroenterology
  Our focus is to help people with diabetes lead healthier, happier lives. That’s why we’re dedicated to developing the next generation of technology that will provide glucose readings faster, and with less inconvenience, to help patients take charge of their diabetes...

  Read More
• Women’s Health
  At Abbott, we know that laboratories performing at their best, deliver results that drive better patient outcomes and improve healthcare value. To help our customers achieve measurably better healthcare performance, Abbott has created a new way — an approach that...

  Read More
• Cardiovascular Disease
  For people living with chronic pain and movement disorders, our portfolio of therapies help them move and feel better, allowing chronic pain patients to reduce or stabilize the long-term use of opioids and get back to living their lives, while helping patients with movement...

  Read More
• Pain/Central Nervous System
  We partner with healthcare professionals worldwide to offer the most trusted names in nutrition products for every stage of life—from nourishing infants and new moms for a healthier start, to providing active adults with the vitamins and minerals they need to perform...

  Read More
• Respiratory Disease
  Driving the potential for global growth.
  
  
  
  

  Read More
• Influenza
  A healthy heart is essential to good health. That's why at Abbott, we throw our hearts into advancing treatments for people with cardiovascular disease. Our breakthrough medical technologies — many of which are minimally invasive — help restore...

  Read More